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Fibronectin is a high molecular weight glycoprotein 
present at cell surfaces and in various body fluids. It is 
involved in cellular adhesion. The frequent absence of 
fibronectin from the surface of malignant cells may con­
tribute to the invasive growth of tumors. To develop a 
better understanding of the functions of fibronectin, we 
have studied its structure by making use of proteolytic 
fragmentation and monoclonal antibodies. Fragments of 
plasma fibronectin which retain one or several of the 
affinities of intact fibronectin have been purified using 
affinity chromatography on collagen and heparin, and 
on monoclonal antibodies. These studies reveal a struc­
ture in which the different functions are located in sep­
arate protease-resistant molecular domains. The NH2-
terminal domain contains the binding sites for fibrin, 
actin, and Staphylococci; this is followed by a collagen­
binding domain, the cell attachment domain, and at the 
COOH-terminal end, the heparin-binding domain. These 
binding sites allow fibronectin to participate in multiple 
interactions with collagens and proteoglycans. The in­
soluble complexes formed by these 3 components that 
can be generated in vitro may represent a model for the 
basic structure of extracellular matrices. The role of 
fibronectin in such a matrix may be to contribute to the 
stability of the complex and to provide adhesion sites for 
cells. Disturbances in the interactions involving fibro­
nectin could be potentially important to understanding 
diseases of connective tissues and in malignancy. 
The mechanisms involved in the interaction of cells with 
their immediate surroundings are thought to be of prime im­
portance for the control of cellular functions such as replication, 
motility, and differentiation. In recent years, rapid progress has 
been made in the analysis of the cell surface and extracellular 
matrix proteins involved in such interactions. One of these 
proteins is fibronectin. 
Fibronectin is a high molecular weight glycoprotein found at 
cell surfaces, in connective tissues, and in the blood and other 
body fluids [for recent reviews, see references 1-:n This protein 
has been demonstrated to interact with many other macromol­
ecules including collagens [4,5], glycosaminoglycans [6-8]. fi­
brinogen and fibrin [9-11], actin [12], and with a structure of 
an unknown nature at the surface of Staphylococci [13,14]. 
Fibronectin mediates the attachment of cells to collagen [15, 
16], and this phenomenon has led to the hypothesis that fibro­
nectin acts as an anchor for cells in the extracellular matrix. 
Furthermore, its incorporation into blood clots [9,17] could 
provide necessary cell attachment sites in wound healing. The 
involvement of fibronectin in the control of cellular morphology 
has also been inferred from the observation that it is absent 
from the surface of many transformed cell lines [1-3]. 
Much of the recent work on fibronectin has focused on 
relating its structure with its multiple molecular interactions. 
In this article, we will review our recent work in this area. 
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DOMAIN STlWCTUHE AND BINDING SITES OF 
FIBHONECTIN 
Proteolytic Fragments of Fibronectin 
To elucidate the structure of the fibronectin molecule, several 
laboratories have isolated, by proteolytic digestion, fragments 
of fibronectin which retain one or more of the activities of the 
whole molecule [1,2,14,18-28]. 
Fibronectin is composed of 2 identical, or nearly identical, 
disulfide-linked polypeptides with a combined molecular weight 
(MW) of about 450,000 [1-3 ] . A main feature of the structure of 
fibronectin is the occurence of independent structural domains 
with different functional activities. Such a domain structure 
was first proposed for fibronectin based on physical me "sure­
ments [29]. The structural and functional information gained 
recently confirms the existence of the domain structure and 
allows us to localize the known active sites in the fibronectin 
polypeptide. 
The fibronectin molecule is highly susceptible to proteolytic 
cleavage and readily yields fragments that have lost the inter­
chain disulfide bond(s) but otherwise retain nearly the entire 
length of the polypeptide [30]. More complete digestion yields 
smaller fragments that are relatively resistant to further pro­
teolysis and seem to represent the active domains of the mole­
cule. Some of the fragments used in our work have been 
generated by digestion of human plasma fibronectin with tryp­
sin, chymotrypsin, or pepsin; others were isolated from a com­
mercial human plasma cryoprecipitate rich in fibronectin frag­
ments that have resulted from plasmin digestion. 
The cryoprecipitate fragments have proven particularly use­
ful in delineating the structure of the fibronectin molecule. 
These are a set of water soluble, gelatin-binding fragments, all 
of which share the same NH2-terminal sequence (Fig 1) [31]. 
Two of these gelatin-binding fragments, the 205 kilo dalton (K) 
and 190K fragments (200K fraction), also bind to glycosami­
noglycans as shown by their binding to heparin-Sepharose. We 
measure cell attachment activity by coating plastic microtiter 
wells with fibronectin, its fragments, or control proteins and 
observing the attachment of added cultured cells to such wells. 
The 200K fraction and a 170K fragment, which lacks the 
heparin-binding activity, promote the attachment of cells while 
a lOOK fragment has only the gelatin-binding activity. 
The 200K fragments can be cleaved further with chymotryp­
sin to give three types of fragments: those binding to gelatin, 
those binding to heparin, and those that do not bind to either 
of these. These latter fragments promote cell attachment. 
The results define the order of the three binding sites in the 
fibronectin polypeptide as gelatin-binding, cell attachment, and 
heparin-binding sites. Of the three binding sites, the gelatin­
binding site is closest to the NH2-terminus. In addition, we 
know from work done by others with fibronectin fragments that 
the NH2-terminal domain which is 27 to 29 kilodaltons in size 
contains the binding sites for fibrin(ogen) and Staphylococci 
[14], and presumably also for actin [1]. Fibrin (and collagen) 
can become covalently cross-linked to fibronectin at a site in 
the NH2-terminal domain in the presence of blood coagulation 
factor XIII (transglutaminase) [17], a phenomenon likely to be 
important in blood coagulation and tissue repair. 
Monoclonal Antibodies to Fibronectin 
Further analysis of the fibronectin structure has recently 
been possible with monoclonal antibodies. Using the technique 
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FIG 1. A schematic representation of plasmin fragments from 
plasma cryoprecipitate and their localization in the fibronectin poly­
peptide. 
of Kohler and Milstein [32], we have prepared a set of hybri­
domas producing antibody specific for fibronectin [33]. Eighty 
hybridoma cultures were obtained which contained antibody 
that reacted with fibronectin in an enzyme-immunoassay 
(ELISA) [34]. 
Four hybridomas-333, 333, 3El, and 4B2-cloned by limit­
ing dilution were chosen based on their different reactivities 
with the fibronectin fragments for expansion as ascitic tumors 
in syngeneic mice. All of these hybridomas are producers of 
IgG1 antibody. 3El and 3E3 react with determinants near the 
heparin-binding portion of the molecule, while 4B2 reacts with 
a site close to the gelatin-binding site. Figure 2 shows an 
example of the reactivity obtained with the 3E3 antibody 
against fibronectin fragments in ELISA (refer to Fig 1). The 
antigenic site for the 3E3 antibody is in the part of fibronectin 
that binds to cells. It was not surprising, therefore, to find that 
the 3E3 antibody interferes with attachment of cells to fibro­
nectin (Fig 3). None of the other monoclonal antibodies, or a 
combination of them, has the capacity to prevent attachment 
of cells to fibronectin. The cell attachment-inhibiting 3E3 an­
tibody has allowed us to isolate a 15 kilodalton peptic fragment 
of fibronectin that contains the cell attachment site. This frag, 
ment was purified by affinity chromatography on the 3E3 
antibody insolubilized on Sepharose. This fragment was active 
in promoting cell attachment but lacked the other known 
binding activities of fibronectin. It could be localized between 
the collagen-binding and heparin-binding domains about 127-
197 kilo dalton from the NH2-terminus of the polypeptide. These 
studies show that the cell attachment-promoting activity of 
fibronectin is contained in a short, defined portion of the 
fibronectin polypeptide and establish its position in the mole­
cule. This region can now be readily detached and isolated 
using the 3E3 monoclonal antibody. This should facilitate fur­
ther exploration of the nature of the fibronectin-cell interaction, 
especially the identification of the molecule(s) at the cell surface 
that interacts with fibronectin. 
FIBRONECTIN-PROTEOGLYCAN -COLLAGEN 
COMPLEXES 
It has been known for some time that heparin and some other 
glycosaminoglycans enhance the binding of fibronectin to col­
lagen [7,8]. More recently, we have shown that a proteoglycan 
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has a similar effect. We have isolated a proteoglycan from a rat 
yolk sac tumor and characterized it as a chondroitin sulfate 
proteoglycan with a cell surface distribution [35]. This proteo­
glycan precipitates native collagen from neutral salt solutions 
and addition of fibronectin in such precipitation mixtures re­
sults in incorporation of fibronectin to the precipitate [36]. 
Treatment of the proteoglycan with alkali to separate the 
glycosaminoglycan chains from the protein part and digestion 
of the protein part with papain abolish the capacity of the 
proteoglycan to precipitate collagen and fibronectin, showing 
that the proteoglycan structure is important for its activity. We 
have proposed that proteoglycan-induced self-assembly of in­
soluble fibronectin-proteoglycan-collagen complexes could, 
along with collagen fibril formation, be of basic importance for 
the formation of extracellular matrix. 
Another aspect of interest is the possible utility of the fibro­
nectin-proteoglycan-collagen complexes as defined models for 
extracellular matrices. Matrices isolated from different tissues 
have been found to have profound effects on cellular growth 
and differentiation [38]. We have recently begun to study the 
effects of reconstituted matrices on cellular behavior. 
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FIG 2. Titration by ELISA [34] of binding of monoclonal antibodies 
to coated microtiter wells [33]. Monoclonal antibody 3E3 binds to 
human fibronectin (0) and its 200K (e) and l70K (6) fragments, but 
not to the lOOK (0) fragment. 
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FIG 3. Cell attachment assay performed on micro titer wells coated 
with fibronectin. After coating, various amounts of 3 monoclonal anti· 
bodies were incubated in the wells and the cells were placed in the wells 
after removal of excess antibody by washing. The 3E3 antibody (e­
e) inhibits attachment of cells to the fibronectin-coated wells, whereas 
the 3El (e- - -e) and 4B2 (e- - -e) antibodies do not. 
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FIBRONECTIN INTERACTIONS AT CELL SURFACE 
AND TISSUES 
Available knowledge about structural arrangements in the 
fibronectin molecule and its interactions provides some insight 
into the function of this protein at the cell surface and in 
plasma. The collagen- and fibrin-binding activities are likely to 
be involved in anchoring of fibronectin to extracellular matrix 
and to a fibrin clot, respectively. In a wound, this might provide 
a scaff()lding to which the penetrating cells could attach . 
The mechanism and significance of the frequent lack of 
fibronectin at the surface of malignant cells are not well under­
stood, but the lack of surface fibronectin is believed to playa 
role in the invasive behavior of tumor cells. This aspect of 
fibronectin has been extensively reviewed [1-3]. For the pur­
poses of this discussion, it is of interest that malignant cells 
lacking surface fibronectin do produce fibronectin, but unlike 
normal cells, release virtually all of their fibronectin into the 
culture medium. Such fibronectin has been isolated from virally 
transformed rat kidney cells (TRK). The TRK fibronectin 
appears to be normal in all tests that have been used to 
characterize it, including its ability to become incorporated into 
the cell surface matrix of normal cells [39]. In the case of the 
THK cells, it has also been documented that their cell surfaces 
are capable of interacting with fibronectin. This is shown by 
the ability of these cells to attach to surfaces coated with 
fibronectin. This suggests that they have the cell surface recep­
tor(s) for fibronectin and that the lack of surface fibronectin, 
therefore, is not due to the lack of such receptors in the TRK 
cells. In other types of cells, the defect may be at the level of 
the receptor. The 3E3 monoclonal ant.ibody which is capable of 
inhibit ing interaction of the cell surface receptor with fibronec­
tin could be utilized to test this hypothesis . 
We are currently also considering the possibility that the lack 
of the cell surface fibronectin in TRK cells (and possibly other 
malignant cells) could be due to an abnormality of proteogly­
cans. As discussed above, proteoglycans can cause insolubiliza­
tion of fibronectin and collagen . Such interactions may secure 
incorporation of fibronectin into the extracellular matrix and 
could leave the cell attachment site of fibronectin available for 
binding of cells to the matrix. 
The collagen and proteoglycan-binding activities are not suf­
ficient, however, for the binding of fibronectin to extracellular 
matrix. We have shown that intact human plasma fibronectin 
injected into the circulation of mice becomes incorporated into 
the tissues in a manner that makes its distribution indistinguish­
able from that of the mouse's own fibronectin in immunofluo­
rescence [40). In contrast, the 200K fragments which bind to 
both collagen and heparin but are truncated at both ends of the 
molecule do not show tissue incorporation (Fig 4). These frag­
ments lack the NH2-terminal domain as well as the interchain 
disulfide bond(s). These structural properties may, therefore, 
play a role in the matrix incorporation. As the molecular basis 
of the insolubilization of fibronectins in tissues becomes known, 
it should also be possible to evaluate the significance of patho­
logical accumulations of tissue fibronectin such as that found in 
the involved skin areas of scleroderma patients [41]. 
The incorporation of plasma fibronectin into tissue matrix 
[40] suggests that one of the functions of the circulating fibro­
nectin is to provide a source of tissue fibronectin. Plasma 
fibronectin has also been found to function as an opsonin. 
Particles coated with gelatin are taken up more efficiently by 
liver slices and macrophages in the presence of fibronectin (see 
reference 42). It seems that these phenomena are mediated by 
the collagen-binding and cell attachment sites in the fibronectin 
molecule . Collagen, fibrin, and actin are the main insoluble 
proteins at the site of tissue injury. The binding of fibronectin 
to these proteins may not only facilitate cell attachment and 
growth but may also enhance phagocytosis of cellular debris in 
these areas. 
FIG 4. Immunofluorescent staining showing the incorporation of 
human fibronectin into mouse kidney 1 issue [40], Human plasma fibro­
ned in or 200K fragments were injected intravenously into mice and 
secl ions of the kidney from such mice or control mice (A and B) were 
stained with antibodies specific for human or mouse fibronectins . Panel 
A shows staining of the kidney of an uninjected mouse for mouse 
fibronectin. There is no staining of such kidney with the species-specific 
anti-human fibronectin (B). Section of kidneys injected with the 200K 
fragment (C) shows some staining for human fibronectin in the glo­
meruli. In mice injected with intact human fibronectin (D) the injected 
fibronectin found in the same locations as mouse fibronectin (compare 
A and D). The insert shows the appearance of the 200K fragments and 
intact fibronectin in sodium dodecyl sulfate/polyacrylamide gel electro­
phoresis under reducing conditions. 
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